Amphotericin B Cholesteryl Sulfate Complex (ABCD) is a generic drug of amphotericin B colloidal dispersion. This study aimed to explore the safety and efficacy of ABCD in patients with invasive mold disease.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
67
intravenous infusion
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, China
Incidence and severity of adverse events (AEs)
Time frame: Up to 14 weeks
The percentages of the patients who completed the 2 week ABCD therapeutic regimen
Time frame: Up to 12 weeks
The percentages of the patients who completed the 4 week ABCD therapeutic regimen
Time frame: Up to 12 weeks
The percentages of the patients who completed the 6 week ABCD therapeutic regimen
Time frame: Up to 12 weeks
The proportion of patients achieving the clinical response of complete remission (CR), partial remission (PR) or stable disease (SD)
Time frame: Up to 12 weeks
The proportion of patients achieving the clinical response of CR or PR
Time frame: Up to 12 weeks
The proportion of patients with a microbiological response of eradication or presumed eradication
Time frame: Up to 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.